These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38542317)
1. Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study. Gallego-Tamayo B; Santos-Aparicio Á; Yago-Ibáñez J; Muñoz-Moreno L; Lucio-Cazaña FJ; Fernández-Martínez AB Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542317 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo. Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192 [TBL] [Abstract][Full Text] [Related]
8. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study. Iwakura T; Fukasawa H; Kitamura A; Ishibuchi K; Yasuda H; Furuya R PLoS One; 2020; 15(2):e0229377. PubMed ID: 32084231 [TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes. Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619 [TBL] [Abstract][Full Text] [Related]
10. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. Kanasaki K Clin Sci (Lond); 2018 Feb; 132(4):489-507. PubMed ID: 29491123 [TBL] [Abstract][Full Text] [Related]
11. Odds of Acute Kidney Injury in Patients Receiving Dipeptidyl Peptidase 4 Inhibitors: A National Cohort Study Within the Department of Veterans Affairs. Sutton SS; Magagnoli J; Cummings TH; Hardin JW Clin Transl Sci; 2019 Nov; 12(6):698-703. PubMed ID: 31420973 [TBL] [Abstract][Full Text] [Related]
12. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats. Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445 [TBL] [Abstract][Full Text] [Related]
13. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates Endothelial Inflammation and Microvascular Thrombosis in a Sepsis Mouse Model. Wang SC; Wang XY; Liu CT; Chou RH; Chen ZB; Huang PH; Lin SJ Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328486 [TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibitors and ischemic myocardial injury. Yoon AH; Ye Y; Birnbaum Y J Cardiovasc Pharmacol Ther; 2014 Sep; 19(5):417-25. PubMed ID: 24607763 [TBL] [Abstract][Full Text] [Related]
15. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes. Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938 [TBL] [Abstract][Full Text] [Related]
16. Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors. Chen CY; Wu VC; Lin CJ; Lin CS; Pan CF; Chen HH; Lin YF; Huang TM; Chen L; Wu CJ; Mayo Clin Proc; 2018 Dec; 93(12):1760-1774. PubMed ID: 30343892 [TBL] [Abstract][Full Text] [Related]
17. Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts. Rebordosa C; Thomsen RW; Tave AK; Madsen M; Beachler DC; Martinez D; Garcia-Esteban R; Plana E; Tormos A; Farsani SF; Perez-Gutthann S; Pladevall-Vila M Diabetes Obes Metab; 2024 Apr; 26(4):1291-1304. PubMed ID: 38234181 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases. Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146 [TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647 [TBL] [Abstract][Full Text] [Related]
20. Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury. Zhao M; Sun S; Huang Z; Wang T; Tang H Clin J Am Soc Nephrol; 2020 Dec; 16(1):70-78. PubMed ID: 33376101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]